DNAtrix - Articles and news items

Merck and DNAtrix announce glioblastoma collaboration

Industry news / 2 October 2015 / Victoria White

Merck and DNAtrix will evaluate the efficacy and safety of DNX-2401 in combination with Keytruda in a Phase 2 study…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+